论文部分内容阅读
目的研究联合抗栓治疗心肌梗死的临床疗效。方法本研究选择我院2013年4月—2015年6月收治的100例心肌梗死患者作为分析对象,并随机将其100例患者分作观察组与对照组,各组50例。本院给予对照组患者常规治疗,即使用阿司匹林联合低分子肝素治疗法进行治疗,观察组患者给予常规治疗,加之以左卡尼汀治疗。对两组患者在治疗前后的各项指标进行分析比较。结果通过对患者进行有效的治疗,观察组治疗的总有效率显著高于对照组,两组比较差异具有统计学意义(P<0.05)。结论给予心肌梗死患者联合抗栓治疗能有效的改善患者的病情发展,进而有效的减轻患者冠状动脉的受损,减低了炎症的进一步发展,临床疗效显著,在临床上值得进一步推广和应用。
Objective To study the clinical efficacy of combined antithrombotic therapy in the treatment of myocardial infarction. Methods In this study, 100 patients with myocardial infarction who were treated in our hospital from April 2013 to June 2015 were selected as the analysis subjects. 100 patients were randomly divided into observation group and control group, with 50 patients in each group. The control group patients given routine treatment, that is, using aspirin combined with low molecular weight heparin therapy for treatment, observation group patients given conventional treatment, combined with levocarnitine treatment. The two groups of patients before and after treatment in the indicators were analyzed and compared. Results Through effective treatment of patients, the total effective rate of observation group was significantly higher than the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion Combined antithrombotic therapy in patients with myocardial infarction can effectively improve the patient’s disease progression, thereby effectively reducing the damage of coronary artery in patients and reducing the further development of inflammation. The clinical curative effect is significant and is worthy of further promotion and application in clinic.